Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation

Journal of Tropical Pediatrics

Volumn 48, Issue 6, 2002, Pages 366-370

  Jaja, S I ^a   Ikotun, A R ^a   Gbenebitse, S ^a   Temiye, E O ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; HEMOGLOBIN;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE FRAGILITY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; SICKLE CELL ANEMIA; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION;

ANEMIA, SICKLE CELL; ASCORBIC ACID; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; ERYTHROCYTES, ABNORMAL; FEMALE; FETAL HEMOGLOBIN; HEMATOCRIT; HUMANS; MALE; NIGERIA; OSMOTIC FRAGILITY;

EID: 0036910048     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/48.6.366     Document Type: Article

References (23)

1. Sen CK. Oxidants and antioxidants in exercise. J Appl Physiol 1995; 79: 675-86.
2. Evans WJ. Vitamin E, vitamin C and exercise. Am J Clin Nutr 2000; 72 (Suppl): 647S-52S.
3. Clarkson PM, Thompson HS. Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr 2000; 72 (Suppl): 637S-46S.
4. Hochstein P, Ernster L. ADP-activated lipid peroxidation coupled on TPNH oxidase system of microsomes. Biochem Biophys Res Commun 1963; 12: 388-94.
5. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-14.
6. Davies KJA. Protein modification by oxidants and the role of proteolytie enzymes. Biochem Soc Trans 1992; 21: 346-53.
7. Parker L. Oxidants, antioxidant nutrients and the athlete. J Sports Sci 1997; 15: 353-63.
8. Chiu D, Vichinsky E, Ho S, et al. Vitamin C deficiency in patients with sickle cell anemia. Am J Pediatr Hematol Oncol 1990; 12: 262-67.
9. Adelekan DA, Thurnham DI, Adekile AD. Reduced antioxidant capacity in paediatric patients with homozygous sickle cell disease. Eur J Clin Nutr 1989; 43: 609-14.
10. Westerman MP, Zhang Y, McConnell JP, et al. Ascorbate levels in red blood cells and urine in patients with sickle cell anemia. Am J Hematol 2000; 65: 174-75.
11. Lachant NA, Tanaka KR. Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid. Am J Med Sci 1986; 292: 3-10.
12. Jaja SI, Kehinde MO. Gbenebitse S, et al. Effect of vitamin C on arterial blood pressure, irreversibly sickled cells and osmotic fragility in sickle cell anemia subjects. Niger J Physiol Sci 2000; 16: 14-18.
13. Jensen WN, Rucknagel DL, Taylor WJ. In vivo study of the sickle cell phenomenon. J Lab Clin Med 1960; 56: 854-65.
14. Dacie JV, Lewis SM. Practical Haematology, 7th edn, Churchill Livingstone, Edinburgh, 1991; 755-56.
15. Trout DI. Vitamin C and cardiovascular risk factors. Am J Clin Nutr 1991; 53 (Suppl 1): 322S-5S.
16. Koh ET. Effects of vitamin C on blood parameters of hypertensive subjects. J Oklahoma State Med Assoc 1984; 77: 177-82.
17. Denengberg BS, Criner G, Jones R, et al. Cardiac function in sickle cell anemia. Am J Cardiol 1983; 51: 1674.
18. Jaja SI, Opesanwo O, Mojiminiyi FBO, et al. Lung function, haemoglobin and irreversibly sickled cell in sickle cell patients. West Afr J Med 2000; 19: 225-29.
19. Sherman DL, Keaney JF, Biegelsen ES, et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000; 35: 936-41.
20. Rodgers GP, Dover GJ, Uyesaka N, et al. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. New Eng J Med 1993; 328: 73-80.
21. Dean J, Schechter AN. Sickle cell anemia: Molecular and cellular bases of therapeutic approaches. New Eng J Med 1978; 299: 804-11.
22. Kaul DL, Nagel RL, Cen D, et al. Sickle erythrocyte-endothelial interactions in microcirculation: The role of Von Willebrand factor and implications for vaso-occlusion. Blood 1993; 81: 2429-38,
23. Mojiminiyi FBO, Larmie ET, Owolabi OA. The osmotic fragility of normal and sickle erythrocytes. Niger Med Pract 1995; 30: 66-8.